New cervical screening

Complete the nine sections; the result classification is computed on submit. This is a classification form — there is no numeric score.

  1. Context
  2. Patient
  3. Eligibility
  4. Consent
  5. Symptoms
  6. Adequacy
  7. HPV
  8. Cytology
  9. Note
Step 1 of 9 — Encounter context

Who took the sample, in what role and setting, and when.

Step 2 of 9 — Patient identification

Local identifier, NHS number, age, and date of birth. Age drives eligibility.

Routine screening applies to ages 25-64. An age outside the range ceases the screen.

Step 3 of 9 — Eligibility

Recall interval, screen-due date, and whether the person is overdue or has formally ceased screening. A ceased record ends the pathway with no recall.

Step 4 of 9 — Consent

Informed consent to take the sample and process the result. A result must not be reported without recorded consent.

Step 5 of 9 — Symptoms

Abnormal bleeding, discharge, or pain. A symptomatic person is managed on the symptomatic (NICE NG12) pathway irrespective of the screening result — a negative screen does not exclude cancer.

Step 6 of 9 — Sample adequacy

An inadequate sample is never HPV-classified; it is repeated in ~3 months (three consecutive inadequate samples escalate to colposcopy).

Step 7 of 9 — Primary hrHPV result

The primary high-risk HPV test. A negative result returns the person to routine recall; only a positive result proceeds to reflex cytology.

Step 8 of 9 — Reflex cytology

Reflex cytology is performed only on an hrHPV-positive sample. It refines a positive result into normal (12-month repeat), low-grade abnormal (routine colposcopy), or high-grade abnormal (urgent colposcopy).

Reflex cytology does not apply: the primary hrHPV result is not positive. Record a positive hrHPV result in the previous step to grade reflex cytology.

Step 9 of 9 — Clinical note and result

Live result classification and management action, plus a free-text clinical note. Submit to generate the full report.

Pending Awaiting result · Incomplete